🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for Pediatric Migraine

Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine NCT07354126NA1 site📍 Lahore Muhammad Aamir Latif · Tests: Flunarizine, Propranolol A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine NCT07454798NA1 site📍 Kansas City Children's Mercy Hospital Kansas City · Tests: Immersive Neurofeedback Self-Regulation Training (INSeRT), Virtual Reality Imagery (No Neurofeedback) A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine NCT06995729Phase 114 sites📍 Washington D.C.📍 Hinesville📍 Minneapolis Pfizer · Tests: Zavegepant A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years NCT06810505Phase 366 sites📍 Huntsville📍 Fayetteville📍 Little Rock AbbVie · Tests: Atogepant, Placebo for Atogepant Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Randomized Study in Children and Adolescents With Migraine: Acute Treatment NCT04649242Phase 3246 sites📍 Birmingham📍 Scottsdale📍 Tempe Pfizer · Tests: Rimegepant/BHV3000, Matching placebo Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects NCT05156398Phase 393 sites📍 Fort Smith📍 Hawthorne📍 La Mesa Pfizer · Tests: Rimegepant, Placebo Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine NCT04743141Phase 3124 sites📍 Scottsdale📍 Tempe📍 Anaheim Pfizer · Tests: Rimegepant (PF-07899801) Responding With Evidence and Access for Childhood Headaches NCT05889624NA15 sites📍 Birmingham📍 Phoenix📍 San Francisco Children's Hospital Medical Center, Cincinnati · Tests: CBT, Amitriptyline Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients NCT06309251n/a3 sites📍 Milan📍 Pavia📍 Roma Danone Nutricia SpA Società Benefit · Tests: ketogenic diet (as per clinical practice) A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine NCT05711394Phase 398 sites📍 Huntsville📍 Saraland📍 Little Rock AbbVie · Tests: Atogepant, Placebo-Matching Atogepant Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Migraines and Tension Type Headache NCT06921109NA1 site📍 Sart Tilman University of Liege · Tests: Experimental: Relaxation training with VR, Experimental: Relaxation training without VR, No Intervention: Control group A Study of Eptinezumab in Pediatric Participants With Episodic Migraine NCT05897320Phase 360 sites📍 Stamford📍 Gulf Breeze📍 Hialeah H. Lundbeck A/S · Tests: Eptinezumab, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy